Valuation : Illumina, Inc.

Market Cap 32.2B 27.71B 26B 23.79B 44.4B 3,044B 44.75B 308B 120B 1,556B 121B 118B 5,010B P/E 2026 *
43.1x
P/E 2027 * 36.5x
Enterprise Value 32.45B 27.92B 26.2B 23.97B 44.74B 3,067B 45.09B 310B 121B 1,567B 122B 119B 5,048B EV / Sales 2026 *
7.02x
EV / Sales 2027 * 6.41x
Free-Float
74.98%
Yield 2026 *
-
Yield 2027 * -
1 day+1.27%
1 week-5.03%
Current month+1.22%
1 month+9.12%
3 months+26.50%
6 months+66.90%
Current year+64.86%
1 week 206.82
Extreme 206.82
225.1
1 month 186.64
Extreme 186.64
231.81
Current year 112.65
Extreme 112.65
231.81
1 year 88
Extreme 88
231.81
3 years 68.7
Extreme 68.7
231.81
5 years 68.7
Extreme 68.7
469.87
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap. Importance
27/08/26
Corvex Management LP
SellCompany -138,379 0.0915%
25/08/26 Other

Director

0 0%
21/08/26
Corvex Management LP
SellCompany -299,336 0.1978%
Change 5-day change 1-year change 3-year change Capi.($)
+1.27%-5.03%+125.08%+35.63% 32.2B
+0.48%-3.18%+26.02%+12.66% 225B
-0.66%-3.31%+4.56%-20.05% 148B
-0.99%+0.43%-16.44%+19.82% 131B
-2.52%+0.73%-56.28%-11.80% 70.1B
-1.27%-0.21%+10.52%+18.16% 52.35B
-1.65%-1.15%-16.82%-14.83% 50.91B
-1.17%-5.22%+19.35%+25.88% 42.68B
-0.22%-2.37%+41.79%+48.83% 40.5B
-0.65%-2.55%-14.66%+49.29% 33.3B
Average -0.70%-2.19%+12.31%+16.36% 82.6B
Weighted average by Cap. -0.56%-2.35%+7.48%+9.36%

Financials

2026 *2027 *
Net sales 4.62B 3.98B 3.73B 3.42B 6.38B 437B 6.43B 44.17B 17.2B 223B 17.37B 16.99B 720B 4.91B 4.23B 3.97B 3.63B 6.77B 464B 6.82B 46.91B 18.27B 237B 18.44B 18.04B 764B
Net income 760M 654M 614M 562M 1.05B 71.88B 1.06B 7.26B 2.83B 36.73B 2.86B 2.79B 118B 891M 767M 720M 658M 1.23B 84.25B 1.24B 8.51B 3.32B 43.05B 3.35B 3.27B 139B
Net Debt 246M 212M 199M 182M 339M 23.26B 342M 2.35B 915M 11.89B 924M 904M 38.28B -729M -627M -589M -539M -1.01B -68.91B -1.01B -6.96B -2.71B -35.22B -2.74B -2.68B -113B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
03/09/26 $216.08 +1.32% 408,020
02/09/26 $213.25 +2.95% 1,771,946
01/09/26 $207.13 -3.04% 1,501,398
31/08/26 $213.63 -0.91% 2,017,763
28/08/26 $215.59 -5.31% 1,791,898
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
213.25USD
Average target price
199.63USD
Spread / Average Target
-6.39%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock